Invectys to Provide 2022 Business Outlook at the H.C. Wainwright Bioconnect Virtual Conference
06 janv. 2022 09h00 HE
|
Invectys, Inc.
Houston, Texas, USA, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Invectys Inc. will participate in the H.C. Wainwright Bioconnect Virtual Conference January 10-13, 2022. Praveen Tyle, Ph.D., Invectys Inc....
Daxor Corporation to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
06 janv. 2022 08h00 HE
|
Daxor Corporation
Oak Ridge, TN, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that CEO and President Michael Feldschuh...
BioRestorative Therapies to Present at H.C. Wainwright BioConnect Virtual Conference
06 janv. 2022 06h00 HE
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Jan. 06, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company" or “BioRestorative”) (NASDAQ:BRTX), a life sciences company focused on stem cell-based therapies,...
Longboard Pharmaceuticals to Present at the H.C. Wainwright BioConnect Virtual Conference
05 janv. 2022 08h30 HE
|
Longboard Pharmaceuticals, Inc.
SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for...
Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright BioConnect Virtual Conference
05 janv. 2022 07h00 HE
|
Silence Therapeutics plc
Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright BioConnect Virtual Conference 5 January 2022 LONDON, Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), a...
Vallon Pharmaceuticals to Present at the H.C. Wainwright BioConnect Conference
04 janv. 2022 08h05 HE
|
Vallon Pharmaceuticals Inc.
PHILADELPHIA, PA, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the...
Cocrystal Pharma to Present at the H.C. Wainwright BioConnect Virtual Conference
04 janv. 2022 08h00 HE
|
Cocrystal Pharma, Inc.
BOTHELL, Wash., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that management will present a company overview at the H.C....
Onconova Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
04 janv. 2022 08h00 HE
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
Arbutus to Participate at H.C. Wainwright Bioconnect Virtual Conference
04 janv. 2022 07h30 HE
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on discovering, developing and...
Daxor to Present at the Inaugural H.C. Wainwright BioConnect 2021 Conference
08 janv. 2021 08h30 HE
|
Daxor Corporation
NEW YORK, Jan. 08, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology (organized as an investment company with fully-owned...